Autolus Therapeutics (AUTL) Depreciation and Depletion (2018 - 2025)

Autolus Therapeutics' Depreciation and Depletion history spans 5 years, with the latest figure at $2.1 million for Q4 2025.

  • For Q4 2025, Depreciation and Depletion rose 5.0% year-over-year to $2.1 million; the TTM value through Dec 2025 reached $8.3 million, up 9.21%, while the annual FY2025 figure was $8.3 million, 9.21% up from the prior year.
  • Depreciation and Depletion reached $2.1 million in Q4 2025 per AUTL's latest filing, roughly flat from $2.1 million in the prior quarter.
  • In the past five years, Depreciation and Depletion ranged from a high of $2.1 million in Q2 2025 to a low of $1.4 million in Q3 2023.
  • Average Depreciation and Depletion over 4 years is $1.8 million, with a median of $1.9 million recorded in 2023.
  • Peak YoY movement for Depreciation and Depletion: fell 22.22% in 2023, then soared 35.71% in 2024.
  • A 4-year view of Depreciation and Depletion shows it stood at $1.6 million in 2022, then grew by 12.5% to $1.8 million in 2023, then increased by 11.11% to $2.0 million in 2024, then rose by 5.0% to $2.1 million in 2025.
  • Per Business Quant, the three most recent readings for AUTL's Depreciation and Depletion are $2.1 million (Q4 2025), $2.1 million (Q3 2025), and $2.1 million (Q2 2025).